567 related articles for article (PubMed ID: 30033758)
1. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
[TBL] [Abstract][Full Text] [Related]
2. Drug screening for ALS using patient-specific induced pluripotent stem cells.
Egawa N; Kitaoka S; Tsukita K; Naitoh M; Takahashi K; Yamamoto T; Adachi F; Kondo T; Okita K; Asaka I; Aoi T; Watanabe A; Yamada Y; Morizane A; Takahashi J; Ayaki T; Ito H; Yoshikawa K; Yamawaki S; Suzuki S; Watanabe D; Hioki H; Kaneko T; Makioka K; Okamoto K; Takuma H; Tamaoka A; Hasegawa K; Nonaka T; Hasegawa M; Kawata A; Yoshida M; Nakahata T; Takahashi R; Marchetto MC; Gage FH; Yamanaka S; Inoue H
Sci Transl Med; 2012 Aug; 4(145):145ra104. PubMed ID: 22855461
[TBL] [Abstract][Full Text] [Related]
3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
4. [ALS disease modeling and drug screening using patient-specific iPS cells].
Egawa N; Inoue H
Rinsho Shinkeigaku; 2013; 53(11):1020-2. PubMed ID: 24291866
[TBL] [Abstract][Full Text] [Related]
5. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
[TBL] [Abstract][Full Text] [Related]
6. Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient.
Bossolasco P; Sassone F; Gumina V; Peverelli S; Garzo M; Silani V
Stem Cell Res; 2018 Jul; 30():61-68. PubMed ID: 29800782
[TBL] [Abstract][Full Text] [Related]
7. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
Sun X; Song J; Huang H; Chen H; Qian K
Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
[TBL] [Abstract][Full Text] [Related]
8. Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".
Bilican B; Serio A; Barmada SJ; Nishimura AL; Sullivan GJ; Carrasco M; Phatnani HP; Puddifoot CA; Story D; Fletcher J; Park IH; Friedman BA; Daley GQ; Wyllie DJ; Hardingham GE; Wilmut I; Finkbeiner S; Maniatis T; Shaw CE; Chandran S
Sci Transl Med; 2013 Jun; 5(188):188le2. PubMed ID: 23740897
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells from ALS patients for disease modeling.
Richard JP; Maragakis NJ
Brain Res; 2015 May; 1607():15-25. PubMed ID: 25223906
[TBL] [Abstract][Full Text] [Related]
10. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
Bohl D; Pochet R; Mitrecic D; Nicaise C
Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
[TBL] [Abstract][Full Text] [Related]
11. New In Vitro Models to Study Amyotrophic Lateral Sclerosis.
Myszczynska M; Ferraiuolo L
Brain Pathol; 2016 Mar; 26(2):258-65. PubMed ID: 26780562
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of microneurotrophin drugs developed for treatment of amyotrophic lateral sclerosis.
Bennett JP; O'Brien LC; Brohawn DG
Biochem Pharmacol; 2016 Oct; 117():68-77. PubMed ID: 27498123
[TBL] [Abstract][Full Text] [Related]
13. Motor Neuron Generation from iPSCs from Identical Twins Discordant for Amyotrophic Lateral Sclerosis.
Seminary ER; Santarriaga S; Wheeler L; Mejaki M; Abrudan J; Demos W; Zimmermann MT; Urrutia RA; Fee D; Barkhaus PE; Ebert AD
Cells; 2020 Feb; 9(3):. PubMed ID: 32121108
[TBL] [Abstract][Full Text] [Related]
14. Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis.
Du H; Huo Z; Chen Y; Zhao Z; Meng F; Wang X; Liu S; Zhang H; Zhou F; Liu J; Zhang L; Zhou S; Guan Y; Wang X
Cells; 2023 Mar; 12(6):. PubMed ID: 36980310
[TBL] [Abstract][Full Text] [Related]
15. ALS, a cellular whodunit on motor neuron degeneration.
Karagiannis P; Inoue H
Mol Cell Neurosci; 2020 Sep; 107():103524. PubMed ID: 32629110
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis.
Okano H; Morimoto S; Kato C; Nakahara J; Takahashi S
J Neurochem; 2023 Dec; 167(5):603-614. PubMed ID: 37952981
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
[TBL] [Abstract][Full Text] [Related]
19. A Non-Toxic Concentration of Telomerase Inhibitor BIBR1532 Fails to Reduce
Pandya VA; Crerar H; Mitchell JS; Patani R
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806803
[TBL] [Abstract][Full Text] [Related]
20. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
